Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Vertex Crashes After Pain Drug Flop Outweighs Second-Quarter Beat
04:35pm, Monday, 04'th Aug 2025
Vertex stock crashed late Monday after the company said it wouldn't advance a next-generation pain drug into more testing.
Vertex Pharmaceuticals Likely To Report Q2 Profit; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
01:48pm, Monday, 04'th Aug 2025
Vertex Pharmaceuticals Incorporated VRTX will release earnings results for the second quarter, after the closing bell on Monday, Aug. 4.
3 Unstoppable Stocks to Buy in August
06:45am, Saturday, 02'nd Aug 2025
The "it" factor. Some stocks have it.
How Will VRTX Stock React To Its Upcoming Earnings?
12:20am, Saturday, 02'nd Aug 2025
Vertex Pharmaceuticals (NASDAQ:VRTX) is set to release its earnings on Monday, August 4, 2025. Over the last five years, Vertex's stock has displayed a trend of positive one-day returns in 58% of case
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now
06:30am, Friday, 01'st Aug 2025
The stock market has been a generous vehicle for building investor wealth through the years even though ups and downs are inevitable. If you stay invested in the stock market for decades, gradually an
Stay Ahead of the Game With Vertex (VRTX) Q2 Earnings: Wall Street's Insights on Key Metrics
10:15am, Wednesday, 30'th Jul 2025
Get a deeper insight into the potential performance of Vertex (VRTX) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note
06:51pm, Tuesday, 29'th Jul 2025
Vertex Pharmaceuticals (VRTX) closed at $468.41 in the latest trading session, marking a +1.64% move from the prior day.
Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
10:16am, Tuesday, 29'th Jul 2025
VRTX eyes second-quarter growth with surging Trikafta sales. Investors' focus is likely to be on the progress of Casgevy, and Alyftrek and Journavx launches.
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
10:00am, Tuesday, 29'th Jul 2025
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Monday, 28'th Jul 2025
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The 3 Things That Matter for Vertex Pharmaceuticals Now
07:15am, Monday, 28'th Jul 2025
Vertex Pharmaceuticals (VRTX -0.57%) has been a terrific stock to own over the past decade. The stock has outperformed the market over this period, thanks to consistent financial results and excellent
Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts
06:51pm, Wednesday, 23'rd Jul 2025
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $476.95, signifying a +1.45% move from its prior day's close.
3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results
04:14am, Tuesday, 22'nd Jul 2025
Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, long-term investors should have a balanced approach to potentially positiv
